Statements (28)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:fragrance
|
gptkbp:bfsLayer |
3
|
gptkbp:bfsParent |
gptkb:Claritin
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:brand |
gptkb:Claritin
|
gptkbp:category |
Category B
|
gptkbp:contraindication |
hypersensitivity to loratadine
|
gptkbp:dosage_form |
10 mg
|
gptkbp:duration |
24 hours
|
gptkbp:form |
gptkb:tablet
gptkb:item |
https://www.w3.org/2000/01/rdf-schema#label |
Claritin Allergy
|
gptkbp:indication |
hives
perennial allergic rhinitis seasonal allergic rhinitis |
gptkbp:ingredients |
gptkb:loratadine
|
gptkbp:interacts_with |
gptkb:beer
CY P3 A4 inhibitors |
gptkbp:is_available_on |
over-the-counter
|
gptkbp:is_used_for |
allergy relief
|
gptkbp:manufacturer |
gptkb:physicist
|
gptkbp:previous_name |
gptkb:loratadine
|
gptkbp:shelf_life |
2 years
|
gptkbp:side_effect |
fatigue
headache drowsiness dry mouth |
gptkbp:storage |
room temperature
|